Your browser doesn't support javascript.
loading
Comparison of cytomegalovirus (CMV)-specific neutralization capacity of hyperimmunoglobulin (HIG) versus standard intravenous immunoglobulin (IVIG) preparations: Impact of CMV IgG normalization.
Schampera, Matthias Stefan; Schweinzer, Katrin; Abele, Harald; Kagan, Karl Oliver; Klein, Reinhild; Rettig, Ingo; Jahn, Gerhard; Hamprecht, Klaus.
Afiliação
  • Schampera MS; Institute of Medical Virology, University Hospital of Tuebingen, D-72076 Tuebingen, Germany.
  • Schweinzer K; Institute of Medical Virology, University Hospital of Tuebingen, D-72076 Tuebingen, Germany.
  • Abele H; Department of Obstetrics and Gynaecology, University Hospital of Tuebingen, Germany.
  • Kagan KO; Department of Obstetrics and Gynaecology, University Hospital of Tuebingen, Germany.
  • Klein R; Department of Internal Medicine II, Immunopathological Laboratory; University Hospital of Tuebingen, Germany.
  • Rettig I; Department of Internal Medicine, Central Laboratory, University Hospital of Tuebingen, Germany.
  • Jahn G; Institute of Medical Virology, University Hospital of Tuebingen, D-72076 Tuebingen, Germany.
  • Hamprecht K; Institute of Medical Virology, University Hospital of Tuebingen, D-72076 Tuebingen, Germany. Electronic address: klaus.hamprecht@med.uni-tuebingen.de.
J Clin Virol ; 90: 40-45, 2017 05.
Article em En | MEDLINE | ID: mdl-28342316

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Imunoglobulina G / Imunoglobulinas Intravenosas / Citomegalovirus / Anticorpos Neutralizantes / Anticorpos Antivirais Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Imunoglobulina G / Imunoglobulinas Intravenosas / Citomegalovirus / Anticorpos Neutralizantes / Anticorpos Antivirais Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article